|
## Cancer Curing Blood , by Eva Gladek and Joyce Gramza, 06.06.06, http://www.sciencentral.com/articles/view.php3?type=article&article_id=218392802
It's a discovery in animals that would change everything if it turns out to be true in people. An injection of blood cells from cancer-resistant mice cures cancer in ordinary mice. As this ScienCentral News video explains, there may be a way to identify cancer-resistant people.
The End of Cancer?
A universal treatment that would work against any type of cancer has always seemed like a far-fetched fantasy. But now researchers at Wake Forest University have made a discovery in mice that might one day lead to a "magic bullet" against human cancers if it proves to be true in people. Several years ago, the researchers identified a rare strain of mouse immune to high, usually lethal doses of cancer cells. Now they have shown that not only are these mice cancer-resistant, but their immune cells are also capable of curing normal, non-resistant mice of any type of advanced cancer.
As reported in Proceedings of the National Academy of Sciences, lead researcher Zheng Cui and his team injected white blood cells from the cancer-resistant mice into normal mice with aggressive cancers that should have killed them in two to three weeks. Instead, their cancer disappeared.
"Cancer cells had already developed a large tumor in the mice, and at a different place [than] where we put the immune cells in," says Cui, "That would require the immune cells to find them at a different part of the body and then track them down to the site and destroy the cancer cells."
The researchers have bred a large colony of the cancer-resistant mice, all from one mouse they discovered in 1999. In previous studies the team showed that the resistant mice can survive very large doses - up to 3 billion cells - of any kind of cancer. This resistance is passed on genetically in a "perfect Mendelian single dominant gene pattern," says Cui, since the trait is transmitted to roughly half of each resistant-mouse's offspring. On this basis the scientists believe the resistance mutation must be in a single gene.
But after seven years of searching for the gene, the researchers have yet to identify it. "There isn't any reason to think it's not a single gene, it just turns out that analysis of that genetics is somewhat more complex than one would have predicted," says pathologist Mark Willingham, a co-author of the paper.
Their past work also clearly showed that the gene worked by somehow activating the immune systems of these resistant mice to selectively target cancer cells. Their most recent research confirms that the immune cells that do the cancer killing belong to the innate immune system. They recognize cancer cells as foreign and attack them without having any prior exposure to them.
"I think the surprise from this mouse model is that it involves a part of the immune system that would not have been predicted," says Willingham. When the researchers isolated different types of innate immune system cells from the resistant mice and tested them against cancer cells, they got another surprise: the cancer resistance was not confined to just one type of immune cell. "All [the types] can be independently killing [cancer] cells without the other subtypes present," says Cui.
A funder of the study, the Cancer Research Institute, which backs immunological approaches to cancer diagnosis and treatment, is funding collaborations with Bruce Beutler, M.D., an immunogeneticist at the Scripps Research Institute, to help search for the gene, and with Robert D. Schreiber, Ph.D., a molecular immunopathologist at the Washington University School of Medicine in St. Louis, who will test the cancer-resistant cells on his mouse models of naturally arising cancers.
Unconventional ideas
The researchers also developed a blood test that can identify the cancer-resistant mice without having to challenge them with cancer. They hope a similar test might help find and study cancer-resistance in people.
"If this were to be the same in humans we could simply identify cancer-resistant humans and to do the blood transfusion or white blood cell transfusion without even knowing the mechanism to find out whether it will work or not," says Cui, "So that's obviously on everybody's mind."
The researchers say they've heard from many cancer patients and their loved ones excited about the tantalizing possibility that blood and bone marrow banks might also contain cancer curing cells. Cui points out that it could take years to find the gene, and many more to develop and test drugs that target it. In the meantime, his team has begun to test blood samples from healthy people, and have found a wide range of cancer-killing activity in humans. "We are forced and compelled to do this kind of experiment ... I think it's our responsibility as cancer researchers," Cui says. But he also acknowledges that he is having a hard time getting funding for this approach. "It's obviously a very unconventional way of doing science nowadays," he says. "It's not mechanism-based ... it's simple mimicry of what happened in the mice."
Indeed, cell biologist Jill O'Donnell-Tormey, executive director of the Cancer Research Institute, says it's important to first understand the genetic and biological basis of these cancer killing blood cells. "There is some indication that a similar mechanism that we're seeing in these remarkable mice are also present in humans but we think we have a ways to go in terms of doing a good deal of research before we can actually answer that question," she says.
Cui says he would like to pursue both the conventional and unconventional approaches. "We think there might actually be a possibility we could do it without knowing the mechanism," he says, "but of course by knowing the mechanism you could devise many other options, so if one thing doesn't work then you can also find different ways using the same concept. So we think both directions are important."
He notes, however, that if the cell-donation approach were to work in people, it would not need to go through a long FDA approval process. "All the delivery mechanisms are already in place and all the ethical regulations for that direction are already in place. So if we can identify cancer-resistant humans then they could start treating them tomorrow if someone wants to pay for it."
This most recent finding by Cui and his team was published in the May 16, 2006 Proceedings of the National Academy of Sciences (PNAS). The research is funded by the Cancer Research Institute (CRI), National Cancer Institute (NCI), and the Charlotte Geyer Foundation.
to the top
to the top
## Enzymes to cure Cancer: By Nicholas Gonzalez, M.D. http://www.dr-gonzalez.com/history_of_treatment_txt.htm
Nicholas J. Gonzalez, M.D., P.C. Linda L. Isaacs, M.D., 36A East 36th Street, Suite 204, New York, N.Y. 10016, Phone: 212-213-3337, Fax: 212-213-3414
The Scottish embryologist, Dr. John Beard, proposed in 1906 that the pancreatic proteolytic enzymes represent the body's main defense against cancer, and would be useful as a treatment for all types of cancer.1
Particularly during the first two decades of twentieth century, Dr. Beard's thesis attracted some attention in academic circles, and several case reports in the medical literature documented tumor regression and even remission in terminal cancer patients treated with pancreatic enzymes.2,3,4,5,6 In 1911, Dr. Beard published a monograph entitled The Enzyme Therapy of Cancer, which summarized his therapy and the supporting evidence.7
After Dr. Beard's death in 1923, the enzyme therapy was largely forgotten. Periodically, alternative therapists have rediscovered Dr. Beard's work, and used pancreatic proteolytic enzymes as a treatment for cancer.8
Dr. Beard believed the enzymes had to be injected, to prevent destruction by hydrochloric acid in the stomach. However, recent evidence demonstrates that orally ingested pancreatic proteolytic enzymes are acid stable,9 pass intact into the small intestine, and are absorbed through the intestinal mucosa into the blood stream as part of an enteropancreatic recycling process.10,11
I began researching the use of oral pancreatic proteolytic enzyme therapy as a treatment for cancer after completion of my second year at Cornell University Medical College in 1981. At that time, I had the opportunity to meet Dr. William Donald Kelley, the Texas dentist who for twenty years had been treating cancer patients with a complicated nutritional therapy based on Beard's enzyme treatment.
Although Kelley had been attacked in the press because of the unorthodox nature of his work, the Dr. Kelley I met was an unassuming man whose primary wish was to have his controversial work fairly evaluated by the academic medical world. I thought his request reasonable.
My research advisor at Cornell, Dr. Robert A. Good, at the time President of Sloan-Kettering, agreed to support a case review of Kelley's patients, which I continued despite the rigors of third year medical school. During my fourth year at Cornell, I was given a considerable block of time under Dr. Good's direction to investigate Kelley's work and results in a more structured manner.
Eventually, what began as a student project developed into a two-year formal research effort which I pursued during my formal immunology training.
During my study, I reviewed nearly 10,000 of Dr. Kelley's patient records. I interviewed and evaluated intensively over 500 patients with appropriately diagnosed advanced cancer, and summarized my findings in an extended monograph completed in 1986 as partial fulfillment for my fellowship training.
# The written report consisted of several sections. In addition to outlining Kelley's theoretical approach, I discussed at length 50 of his patients initially diagnosed with a variety of poor prognosis cancer, all of whom had enjoyed long term survival and/or apparent regression of disease while following their nutritional regimen. As a separate chapter, I also evaluated all cases of unresectable pancreatic cancer, both compliant and non-compliant, who had come to see Kelley between 1974 and 1982. I eventually identified 22 patients in this group. For all of these patients, I obtained complete medical records, including death certificates for those who were deceased. I interviewed all surviving patients repeatedly and at length, and in the case of those who had died, I interviewed family members as well as the original attending physicians.
Ten of these patients had visited Kelley only once and had never followed the protocol: these individuals had been discouraged from proceeding largely because of the negative influence of family and physicians who thought Kelley to be an outright fraud. This population, with a median survival of only 60 days, served as a convenient control. Among the remaining 12 patients, I found a number who had survived far beyond what would be expected for the disease, including one patient with pancreatic cancer to the liver who had, when last contacted, been alive over ten years from her original diagnosis. (Discoveries in Medicine review http://www.dr-gonzalez.com/maver_article_txt.htm )
Despite the careful documentation and the five-year investment of time, no one in academic medicine could, at the time, accept that a nutritional therapy might produce positive results with advanced cancer patients.
# In 1986, probably as a result of endless pressures, Dr. Kelley gave up research and patient care, and I myself have not spoken to him or any of his associates since 1987. He passed away in January 2005. (Obituary of Dr. Kelley http://www.cancerdecisions.com/021305_page.html ) In 1987, I decided to move to New York to try and salvage the enzyme approach, and observe for myself the results with poor prognosis cancer patients. My goal throughout has been to generate research support, so that this method, if it indeed proved to have value, could be integrated into general medical treatment.
In July of 1993, the then Associate Director for the Cancer Therapy Evaluation Program at the National Cancer Institute invited me to present selected cases from my own practice as part of an NCI effort to evaluate non-traditional cancer therapies. Dr. Isaacs and I prepared for presentation 25 cases representing a variety of poor prognosis or terminal malignancies who had either enjoyed long term survival or tumor regression while following my program. (NIH newsletter description http://www.dr-gonzalez.com/best_cases_txt.htm ) Included in my presentation were patients diagnosed with advanced breast, lung, prostate and other cancers. Most of these patients are still alive, now more than ten years since that presentation.
After the session, the Associate Director suggested we pursue a pilot study of our methods in ten patients suffering inoperable adenocarcinoma of the pancreas, with survival as the endpoint. He suggested pancreatic cancer because the standard survival for the disease is so poor, and an effect could be seen in a small number of patients in a short period of time. In fact,
I was told that if three of ten patients lived a year, that would be considered a positive result. Nestec (the Nestle Corporation) agreed to fund the trial, which began in January 1994. The study has been completed and was published in the June 1999 issue (Volume 33, Number 2) of Nutrition and Cancer.
Of 11 patients followed in the trial, 8 of 11 suffered stage IV disease. Nine of 11 (81%) lived one year, 5 of 11 lived two years (45%), 4 of 11 lived three years (36%) and two have lived longer than four years. In comparison, in a recent trial of the newly approved drug gemcitabine, of 126 patients with pancreatic cancer not a single patient lived longer than 19 months.
(Abstract of article) Subsequently, the National Cancer Institute, in conjunction with the National Center for Complementary and Alternative Medicine, approved funding for a large-scale controlled trial evaluating our approach against chemotherapy, again in patients diagnosed with pancreatic cancer. For those interested in the clinical trial, we have been asked to refer patients to government websites such as an NCI press release and the PDQ site at the NCI.
In addition to these clinical trials, we have also been working collaboratively with basic science researchers to test our enzyme approach in animal models of pancreatic cancer. In May, 2004, the results of these studies were published in the peer-reviewed journal Pancreas. In these experiments, a very aggressive form of pancreatic cancer was induced in mice, then half the animals were given our enzymes, half were given no therapy. Those treated with the enzymes showed a significant improvement in survival and behavior compared to animals not receiving the enzymes.
In a second experiment, tumor growth was substantially reduced, and survival prolonged again, in animals receiving the enzymes.(Abstract of article http://www.dr-gonzalez.com/mice04_txt.htm ) We want to emphasize that the results were particularly significant for a first attempt, since the investigators were using only the enzyme part of our program, and did not use a variety of doses to determine the most optimal for a mouse. As the principal investigator of the study wrote in the conclusion of the article: "In summary, PPE (porcine pancreatic enzyme) is the first experimentally and clinically proven agent for the effective treatment of PC (pancreatic cancer). The significant advantages of PPE over any other currently available therapeutic modalities include its effects on physical condition, nutrition and lack of toxicity."
We also want to emphasize that in our practice we prescribe, and in the pilot study and in the animal experiments we used a formulation of pancreatic enzymes made to our strict specifications. These enzymes are available only to our patients, and are not available over the Internet or in health food stores. In our experience, quality, manufacturing methods, and composition vary widely among commercially available preparations of pancreatic enzymes. The results of our studies cannot be used as validation for any other product, whether obtained from a health food store, a pharmacy or an Internet source.
# Although our published research deals with pancreatic cancer, in our office we treat patients with all types of cancers. We also treat patients with a variety of other problems, ranging from chronic fatigue syndrome to multiple sclerosis. Each treatment protocol is individualized for each patient, regardless of the underlying problem.
The therapy itself is quite complex, but basically involves three components: diet, aggressive supplementation with nutrients and enzymes, and detoxification. The protocols are individualized and each patient receives a diet designed for his or her specific needs. The diets are quite variable, ranging from a pure vegetarian program to a diet requiring fatty red meat 2-3 times a day.
The supplement regimens are also individualized, and intense: each cancer patient consumes between 130 and 175 capsules daily. Non-cancer patients will require considerably fewer supplements per day. The supplement regimens include a range of vitamins, minerals, trace elements, anti-oxidants and animal glandular products, prescribed according to the particular patient's needs and cancer type. These nutrients do not, we believe, have a direct anti-cancer effect, but instead serve to improve overall metabolic function. In addition to these supplements, every cancer patient takes large quantities of freeze dried porcine pancreatic enzymes in capsule form, which we believe provide the main anti-cancer action.
The animal glandular products and pancreatic enzymes that we use are derived from animals raised in Australia and New Zealand, where there has been no history of BSE (mad cow disease) or other prion diseases such as scrapie. The animal husbandry regulations in Australia and New Zealand are the strictest in the world, and prohibit the feeding practices that have caused problems in other countries.
The third component of the protocol involves what we call "detoxification" routines. On this therapy, we find that as patients repair and rebuild, large amounts of metabolic wastes and stored toxins are released. As a result, patients routinely develop a variety of symptoms, most commonly described as "flu-like," such as low grade fevers, muscle aches and pains, even rashes that we hypothesize result from low grade tumor lysis. "Detoxification" refers to procedures such as the coffee enema, which are believed by alternative practitioners to enhance liver function and in turn, the processing and excretion of metabolic wastes. The coffee enemas are done twice daily, and patients most commonly report symptomatic relief.
# Coffee enemas have been discussed in the orthodox medical literature for the better part of this century. Many nursing texts routinely recommended coffee enemas, and the Merck Manual advocated coffee enemas as a stimulant in all editions from the first in 1898 through 1977.12 During the 1920's and 30's, coffee enemas were prescribed for a variety of conditions.13,14,15,16,17 In terms of their physiological effect, studies have shown that the rectal instillation of fluids will stimulate gallbladder contraction and emptying.18
Of the hundreds of Kelley patients I interviewed during my research study, virtually every one reported significant symptomatic relief from the enemas. In my own practice patients repeatedly report the same improved well-being and relief of symptoms after a coffee enema. The enemas, in my experience, appear to be safe: I have yet to document a single serious side effect either in the thousands of Kelley patients I evaluated, or in my own practice. However, I do not encourage anyone to attempt coffee enemas except under the care of a knowledgeable physician.
Our goal remains to have our approach properly tested in an academic environment, and should the results continue to prove positive, to have our work mainstreamed into the orthodox medical world.
(For further information, you may wish to order a lecture tape http://www.dr-gonzalez.com/lecture_tapes_txt.htm . Tapes of lectures given by Dr. Gonzalez over the years to both lay and professional groups are available. These tapes provide more intensive explanations of the program. A recording of Dr. Gonzalez on The Deborah Ray Show is available http://www.dr-gonzalez.com/online_audio_txt.htm on this web site.)
to the top
### Dr HAMER - PSYCHOLOGIC cure for cancer : http://germannewmedicine.ca
A BRIEF BIOGRAPHY :
Dr. Ryke Geerd Hamer, born in 1935 in Frisia (Germany), studied medicine and theology at the University of Tübingen. At the age of 22, he completed his master's degree in theology and then, four years later, received his professional license as a doctor of medicine… In 1972 Dr. Hamer completed his specialization in internal medicine and began to work at the University clinic in Tübingen as an internist in charge of cancer patients. …
… On August 18th, 1978, while in Rome, the Hamer's received the shocking news that their son Dirk had been accidentally shot by the Italian Prince Victor Emanuel of Savoy… Shortly after Dirk's death, Dr. Hamer was diagnosed with testicular cancer. Since he had never been seriously ill, he postulated that the development of his cancer could be directly related to the unexpected loss of his son. In fact, he would eventually, in honor of Dirk, call this unexpected shock a DHS or "Dirk Hamer Syndrome".
… At the time head internist of a cancer clinic at the University of Munich, he began to investigate his cancer patients' histories and soon learned that, like him, they all had experienced an unexpected shock of one sort or another.
… Pursuing the hypothesis that all bodily events are controlled from the brain, he analyzed his patients' brain scans and compared them with the corresponding medical and psychological records. To his amazement, he found a clear correlation between certain "conflict shocks", how these shocks manifest on the organ and how all these processes are connected to the brain. …
Dr. Hamer discovered that every disease originates from a shock or trauma that catches us completely by surprise. The moment the unexpected conflict occurs, the shock strikes a specific area in the brain causing a lesion (later called Hamer Focus), visible on a brain scan as a set of sharp concentric rings. The brain cells that receive the impact send a biochemical signal to the corresponding body cells causing the growth of a tumor, a meltdown of tissue or functional loss, depending on which brain layer receives the shock.
… While the brain stem (the oldest part of the brain) is programmed with basic survival issues like breathing, reproduction and food, the cerebrum (the youngest part of the brain) is more concerned with social and territorial themes. Dr. Hamer also discovered that every disease progresses through two phases: first, a conflict active phase, characterized by emotional stress, cold extremities, a lack of appetite, and sleeplessness, and then, provided we manage to resolve the conflict, a healing phase. This is the period in which the psyche, the brain and the corresponding organ undergo the phase of recovery, an often difficult process marked by fatigue, fever, inflammation, infection, and pain.
Dr. Hamer called his findings "The Five Biological Laws of the New Medicine", since his research is in full accordance with the natural laws of embryology and with evolutionary logic. … Dr. Hamer has been able to confirm his discoveries with over 40,000 case studies.
The result of his scientific work is the creation of a "Psyche-Brain-Organ"-chart that outlines the disease, the content of the biological conflict that cause it, where the corresponding lesion can be seen on a brain scan, how the disease manifests itself in the conflict active phase, and what can be expected in the healing phase (publications: http://www.markolin.com/section1/subsection2/index.shtml ).
… In October 1981, Dr. Hamer presented his research to the University of Tübingen as a post-doctoral thesis. … to his great surprise, the University committee rejected his work and refused to evaluate his thesis, an unprecedented case in the history of universities. There was yet another surprise. Shortly after he had handed in his thesis, Dr. Hamer was given the ultimatum to either deny his findings or his contract would not be renewed. …
… The harassment of Dr. Hamer culminated in 1986, when a court sentence stopped him from practicing medicine. Despite the fact that his scientific work had never been disproved, he lost, at the age of 51, his medical license on the grounds that he refused to renounce his findings on the origin of cancer and to conform to the principles of official medicine.
… In 1997 Dr. Hamer was arrested and sentenced to 19 months in prison for having given three people free medical information without a medical license…. Subsequently, one public prosecutor was forced to admit during the trial that, after five years, 6,000 out of 6,500 patients with mostly 'terminal' cancer were still alive. And so, ironically, it was his opponents that provided the actual statistics attesting to the New Medicine's remarkable success rate….
### The New Medicine of Dr Hamer, by Walter Last [ Rescued web page - March 2004 ] From : http://www.luminet.net/~wenonah/new/hamer.htm
Dr Hamer had an exceptionally high success rate with his cancer therapy, by far the highest I have seen of any therapy. During one of several trials of the persecuted Dr Hamer the public prosecutor (Wiener-Neustadt in Austria) had to admit that after 4 to 5 years 6,000 out of 6,500 patients with mostly advanced cancer were still alive. That is over 90%, almost a reversal of the results to be expected after conventional treatment of advanced conditions…
The Iron Rules of Cancer
1. Every cancer and related disease starts as a DHS that is a Dirk Hamer Syndrome, which is a serious, acute-dramatic and isolating conflict-shock-experience. It manifests simultaneously on three levels, psyche, brain and organ.
2. The theme of the psychic conflict determines the location of the focus or HAMER Herd in the brain, and the location of the cancer in the organ.
3. The course of the psychic conflict correlates with the development of the HAMER Herd in the brain, and the course of the cancer in the organ.
At the moment of the conflict-shock a short circuit occurs in a pre-determined place of the brain. This can be photographed with computed-tomography (CT) and looks like concentric rings on a shooting target or like the surface of water after a stone has been dropped into it. Later on, if the conflict becomes resolved, the CT image changes, an edema develop, and finally scar tissue.
How specific and precisely located these brain lesions are may be seen from the following. After a professional lecture a doctor handed him the brain CT of a patient and asked to explain it. From this Dr Hamer diagnosed the patient to have a fresh bleeding bladder carcinoma in the healing phase, an old prostate carcinoma, diabetes, an old lung carcinoma and sensory paralysis in a specific area, in addition to the corresponding emotional conflicts.
Amazingly, Dr Hamer was able to show that at the same time as the concentric brain lesion appears also the target organ CT may show such a concentric lesion. According to Dr Hamer this happens instantly when the psychic shock hits the subconscious level and this same second is the start of cancer.
However, also other diseases can be caused by the same mechanism. How severe a disease becomes may depend on other psychological, energetic and nutritional factors but its nature and location are determined by the content of the conflict shock.
… When we unexpectedly experience emotional distress, an emergency repair program is set in motion, a biological conflict program with the aim of returning the individual to normal. Such programs can even apply to families or other groups.
Hamer gives the following example:
A mother sees her child in a bad accident. In evolutionary terms small children recover faster when they receive extra milk. Therefore, the biological conflict program tries to stimulate milk production by increasing the number of breast cells. If the mother is right-handed, that will instantly cause the appearance of a Hamer Herd in a specific part of her right brain, which in turn relates to the left breast. When the child is well again, conflict resolution begins and extra milk is no longer needed. The mother gets a benign form of tuberculosis in that breast which breaks up the excess breast cells. However, if the mycobacteria required for this are lacking, then the area may just calcify and remain as a dormant tumor.
… If instead a human gets a cancer diagnosis, even if the diagnosis is wrong, the same biological program is set in motion by the same fear of death that helped the animal to escape. The stress level jumps and the brain-lung connection is activated but now there is nowhere to run. Until the conflict is resolved, which may take years, there will be constant stress as well as brain-induced stimulation of lung activity, which now takes the form of increasing lung capacity by the incessant division of cells.
This process can only be stopped by switching off the trigger in the brain through defusing the original conflict shock. This happens when the patient subsequently has surgery or natural therapy, which he or she fully believes will lead to a cure. However, the same procedure in a patient who has doubts about its effectiveness will leave the conflict unresolved and the disease to progress. …
The selection of the conflict focus occurs by subconscious association. For instance biological conflicts involving water but also other fluids, such as milk or oil, lead to kidney cancer, fear of death to lung cancer and psychologically swallowing a bigger chunk then we can digest to stomach or intestinal cancer.
Originally, in the animal world, it really was a big chunk of food, but for us it may be a financial over-commitment or any other obligation that we have taken on and cannot fulfill. However, the target focus is not determined by the event itself, but rather by the psychological significance that it has for us at the time of the event. …Other typical situations that may lead to biological conflicts are loss situations, loss of a loved one, of a job, a valued possession or a territory.
Dr Hamer believes that most metastases or secondary tumors are caused by the cancer-fear or death-fear resulting from the patient given the cancer diagnosis or a negative prognosis. … Also a diagnosis of colon cancer commonly leads to liver cancer because of a subconscious fear of starvation.
Generally hopelessness, despair and meaninglessness create chronic stress, which prevent the healing from cancer and other diseases but they are not the cause. According to Hamer the real cause of cancer and other diseases is an unexpected traumatic shock for which we are emotionally unprepared. The following list shows some of the relationships between conflict emotions and target organs.
· Adrenal cortex - Wrong direction, gone astray
· Bladder - Ugly conflict, dirty tricks
· Bone - Lack of self-worth, inferiority feeling
· Breast milk gland - Involving care or disharmony
· Breast milk duct - Separation conflict
· Breast, left (right-handed) - Conflict concerning child, home, mother
· Breast, right (right-handed) - Conflict with partner or others
· Bronchials - Territorial conflict
· Cervix - Severe frustration
· Colon - Ugly indigestible conflict
· Esophagus - Cannot have it or swallow it
· Gall Bladder - Rivalry conflict
· Heart - Perpetual conflict
· Intestines - Indigestible chunk of anger
· Kidneys - Not wanting to live, water or fluid conflict
· Larynx - Conflict of fear and fright
· Liver - Fear of starvation
· Lung - Fear of dying or suffocation, including fear for someone else
· Lymph glands - Loss of self-worth associated with the location
· Melanoma - feeling dirty, soiled, defiled
· Middle ear - Not being able to get some vital information
· Mouth - Cannot chew or hold it
· Pancreas - Anxiety-anger conflict with family members, inheritance
· Prostate - Ugly conflict with sexual connections or connotations
· Rectum - Fear of being useless
· Skin - Loss of integrity
· Spleen - Shock of being physically or emotionally wounded
· Stomach - Indigestible anger, swallowed too much
· Testes and Ovaries - Loss conflict
· Thyroid - Feeling powerless
· Uterus - Sexual conflict
The Healing Phase
… It causes a continuous stress resulting in a tendency to develop cold hands and feet, lack of appetite and weight loss, sleeplessness and dwelling all the time on the conflict content. If the conflict does not become resolved soon, the long-lasting stress will lead to specific symptoms and the development of cancer or another disease.
When the conflict resolves, the patient is no longer occupied with the conflict content, the appetite returns, hands are warm again and also normal sleep returns, but there may also be weakness, fatigue and a need to rest. These effects show that the parasympathetic nervous system is now in control. This is the beginning of the healing phase…
…Hamer estimates that 99% of brain events, such as strokes, bleeding into the brain, cysts and tumors are due to healing events of Hamer Herds and with this temporary and self-limiting unless there is inappropriate medical intervention…
…Urea has strong diuretic properties and an excellent effect in cases of dangerously high fluid pressure in the brain. Generally 20 g of urea are used 2 to 5 times daily. One life-threatening case has been described of a massive "brain tumor" re-growth that completely disappeared within 2 hours after receiving 256 ml of 30% urea (described in Your Own Perfect Medicine by Martha Christy, Future Med). This report clearly shows that the presumed brain tumor in fact was a massive edema as postulated in the New Medicine.
… In the first part of the healing phase most problems are due to water retention, inflammations and swelling of tissues that can cause a lot of pain. Hamer regards edema, whether found in the brain or in an organ, as positive, a sign of healing.
Tissue Repair
After the healing crisis adeno-carcinomas are removed by fungi and mycobacteria while hepatitis virus may in addition help to regenerate the liver. At this stage, bacteria, viruses and fungi that help to break down the tumors and repair damaged tissues also cause inflammation, pain and fever.
…The first group has cell proliferation and tumor growth during the conflict phase and then removes excess cells with the help of microbes during the healing phase. The other group causes cell destruction during the conflict phase resulting in ulcers, necroses and tissue holes affecting for instance bones (osteoporosis), kidneys, spleen or ovaries.
During the healing phase, this second group tries to fill in the created holes through cell proliferation. Tissue necroses and osteolyses (dissolved bone) are now repaired by bacteria that first form abscesses, which are then filled in with scar tissue and later with granulating tissue to form osteosarcoma, lymphoma, fibroma and healing cysts. Also leukemia commonly occurs during the healing phase, as after bone marrow damage from radiation, chemicals or bone cancer. …
Healing the Psychic Conflict
The main task in every case of cancer is to find the original emotional shock experience and make sure that it has been healed or is being healed. In many case it will have corrected itself and the patient suffers from an effect of the healing phase.
For instance, someone may have lost a farm or business but has now started another satisfying venture or hobby. As after-effect there may now be a tumor that gradually becomes dormant or eventually disintegrates. About 40% of tumors discovered during routine medical investigations are said to be old and harmless, that is dormant and calcified. …
… We need to think back, especially one to two years before our problem started and analyze our emotional history during this time as well as before and after….
If we still have a strong emotional response when we discover the content of the conflict, then we can be sure that it is still unresolved. If at all possible it is best to solve it in a natural way. For instance if it was caused by losing a partner, then find someone new; if you lost a child, become pregnant again or adopt a child or buy a pet. Cancer does not continue to grow after the third month as pregnancy has priority.
…In addition, I firmly believe that all active conflicts will be terminated and the healing phase begin when we are able to strongly feel love and forgiveness within ourselves and then radiate it to all others but especially to anyone who we feel might have wronged us…
… It is different in our society as the natural healing process is routinely interfered with. It starts with getting tranquilizers or antidepressants during the active conflict phase, which prevent us from fighting back and regaining our territory. This may then lead to a cancer diagnosis that causes an additional active conflict and ends with morphine, which totally disables our healing responses.
While Hamer does not believe that health foods, remedies, cleansing or healthy living in general can cure cancer, these certainly can be important in order to survive the ordeals of the healing phase.
Actually, Hamer regards all diseases as consisting of two phases, initially with active conflict followed (if possible) by a healing phase that reverses the conflict program. He does not call them diseases anymore but rather special biological programs. In all he is stated to have worked with over 31,000 patients and found his theories confirmed in every single case without exception.
Hamer claims that overall the New Medicine has a 95% success rate with cancer.
…However, in 2001 a prominent neurologist openly defended Dr Hamer by publishing a book about the New Medicine and demanding that his theories be officially tested. Because Dr Therese von Schwarzenberg also belongs to the high nobility, the mass media are in a bind on what position to take on this. Until now they have only reported about Dr Hamer in the most derogative ways and here is now that high profile personality who claims that Hamer is right and deserves a Nobel Price!
Nevertheless, the official response of prominent oncologists still remains that it is totally absurd to assume emotions could be important in the cause and cure of cancer and, therefore, Dr Hamer's claims must not be tested.
# Ralph W. Moss, Ph.D. is the author of eight books and three documentaries on cancer-related topics.
He is an advisor on alternative cancer treatments to the National Institutes of Health, Columbia University, and the University of Texas.
He researches and writes individualized "Healing Choices" reports for people with cancer.
For information on Healing Choices, you can contact coordinator Anne Beattie @ 144 St. John's Place, Brooklyn, NY 11217; Phone 718-636-4433; Fax 718-636-0186.
Web site: www.ralphmoss.com . Email: mail@ralphmoss.com.
to the top
|
Parcourez les archives de Tesla3.com en 7 catégories:
Find the older websites here >> http://waterfuel.100free.com and http://waterfuel.t35.com << Trouvez les anciens websites ici 